C19毒苗產生的刺突蛋白*不會*消失→當你*被感染*時或*續打*C19毒苗時，刺突會促進凝血(血栓)→血栓可以跑到你身體任何一個器官，常見就是腦部(腦中風)肺部(肺栓塞)心臟(血栓)....等器官→這就是為何有人打完1-2年後還會中風的原因。刺突會促進發炎(血管炎)→讓你身體所有器官都會發炎，常見的腦部發炎(精神不穩定.癲癇.認知障礙.腦部劇烈頭痛.昏厥.動脈瘤)→這可能就是近日全世界*自撞*車禍增加的原因之一(當事人基本上無法控制)；另一個致命的是心臟發炎(心肌炎)→突然死亡(猝死)的原因(常見起床前和運動時發生)→全世界已經都陸續發生。刺突會*促進*自體免疫疾病產生→刺突會讓身體的免疫系統*錯誤地**攻擊健康細胞*產生自體免疫相關疾病(例如:第一型糖尿病.重症肌無力..類風濕關節炎..僵直性脊椎炎...多發性硬化症 (MS)..炎症性腸病（IBD)..狼瘡...艾迪生氏病..格雷夫斯病.橋本氏病.斑禿..格林-巴利綜合徵 (GBS)...牛皮癬))。刺突會促進內皮細胞損傷(身體的任何一個器官都會→很多人突然間變成*高膽固醇*患者→醫生開立*它丁類*降膽固醇藥物讓你吃→刺突會傷害心臟..它丁類降膽固醇*副作用*更傷害心臟→降低內皮損傷才是上策而不是吃降膽固醇藥物！打過毒苗的人要*預防性吃藥*(不要施打任何一種疫苗)...才能預防上面事件發生，因為刺突蛋白會透過皮膚和空氣傳播，即使你不打毒苗也會再次被感染的可能性，重要的是，伊維菌素是可與刺突蛋白結合的最有效的藥物。因此，如果您體內存在循環的刺突蛋白，無論是自然感染還是疫苗接種，伊維菌素將有助於與其結合，從而防止刺突蛋白的大部分負面影響。*FLCCC*推薦的最佳的預防性(治療C19和解毒)用藥是伊維菌素→請參照FLCCC網站或推特打IVERMECTIN(IVM)就會知道！ 伊維菌素 https://covid19criticalcare.com/ivermectin/ COVID-19 疫苗相關性心肌炎後一年內的心血管評估
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064772 韓國、美國、德國等多個國家已證實心肌炎可導致死亡，包括猝死和接種疫苗後因心肌炎死亡。 定期使用伊維菌素預防 COVID-19，以劑量反應方式使 COVID-19 死亡率降低 92%：對 88,012 名受試者進行嚴格控制的前瞻性觀察研究結果https://www.cureus.com/articles/111851-regular-use-of-ivermectin-as-prophylaxis-for-covid-19-led-up-to-a-92-reduction-in-covid-19-mortality-rate-in-a-dose-response-manner-results-of-a-prospective-observational-study-of-a-strictly-controlled-population-of-88012-subjects#!/ 結論
與常規使用伊維菌素相比，不使用伊維菌素會使死亡率增加 12.5 倍，死於 COVID-19 的風險增加 7 倍。這種劑量反應功效增強了伊維菌素對 COVID-19 的預防作用。

Ivermectin - FLCCC | Front Line COVID-19 Critical Care Alliance

IvermectinFLCCC2023-07-18T12:13:59-05:00 Like penicillin and aspirin, ivermectin is a medication that derives from nature. Although it was little known in advanced health economies before COVID, t

https://covid19criticalcare.com/ivermectin/

Just a moment...

Checking if the site connection is securewww.ahajournals.org needs to review the security of your connection before proceeding.

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064772

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Background We have previously demonstrated that ivermectin used as prophylaxis for coronavirus disease 2019 (COVID-19), irrespective of the regularity, in a strictly controlled citywide progr...

https://www.cureus.com/articles/111851-regular-use-of-ivermectin-as-prophylaxis-for-covid-19-led-up-to-a-92-reduction-in-covid-19-mortality-rate-in-a-dose-response-manner-results-of-a-prospective-observational-study-of-a-strictly-controlled-population-of-88012-subjects#!/

No response has been written yet. It is recommended to maintain a healthy skepticism towards it.